RISalud-ANDALUCÍA
Not a member yet
18682 research outputs found
Sort by
Prevalence of abnormal albuminuria and mildly increased albuminuria in people aged 45 and over in a Mediterranean population with a stratified analysis for diabetes and hypertension
No full textBackground. Albuminuria is recognized as an early marker of kidney injury and an independent predictor of cardiovascular events. Yet the frequency of abnormal albuminuria (AA; UACR ≥ 30 mg/g) and mildly increased albuminuria (MIA; 10–29 mg/g) in Mediterranean populations is still poorly characterized.
Methods. A cross-sectional, multicentre study including all urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) records from July 1, 2021, to June 30, 2023, in individuals ≥ 45 years (23 860 adults [median age 64 years; 54 % women]) within a Health Management Area was done. We used KDIGO 2024 classification, adding a new sub-category for MIA. Prevalence with 95 % confidence intervals (CI) was calculated and stratified by sex, age, diabetes, and hypertension.
Findings. The overall prevalence of AA was 9.2 % (95 % CI 8.8–9.6), higher in men (10.8 %) than in women (7.9 %) and rose steadily with age: 3.9 % (45–59 y), 8.5 % (60–74 y), and 18.1 % (≥ 75 y). AA reached 18.8 % among those with diabetes and 22.7 % in diabetes plus hypertension, versus 3.8 % in only hypertensive people, and 1.5 % without both conditions. An inverse relationship with kidney function was observed (4.0 % in stage G1 versus 55.2 % in G4–G5). MIA was present in 9.9 % (95 % CI 9.5–10.3), showing similar distribution patterns at lower magnitudes; a peak of 16.2 % occurred at eGFR 60–74 mL/ min/1.73 m², falling to 13.1 % in G4–G5.
Interpretation. Abnormal and mildly increased albuminuria affect nearly one in five adults aged 45 and over in Mediterranean primary care. Given its strong association with age, diabetes, hypertension, and declining kidney function, systematic UACR screening- including for MIA- must be prioritized to enable early detection and intervention.Ye
Vol. 30, nº 32. Mordeduras por animales y enfermedades causadas por ellas: 2024.
No full textEnfermedades de Declaración Obligatoria por provincias. Semana 35/2025 y acumulado desde la semana 01/2025. Datos provisionales. Incluye además el artículo titulado “Mordeduras por animales y enfermedades causadas por ellas: 2024”, de “Juan Carlos Carmona Lagares”.Ye
Vol. 30, nº 07. Vigilancia y control de las infecciones relacionadas con la asistencia sanitaria en unidades de cuidados intensivos: protocolo pilotaje vigilancia centralizada en 2024.
No full textEnfermedades de Declaración Obligatoria por provincias. Semana 06/2025 y acumulado desde la semana 01/2025. Datos provisionales. Incluye además el artículo titulado “Vigilancia y control de las infecciones relacionadas con la asistencia sanitaria en unidades de cuidados intensivos: protocolo pilotaje vigilancia centralizada en 2024”, de “Rafael Ruiz Montero, Irene Morales Arjona”.N
Advanced metrology in patiens with axial spondyloarthritis: lumbar or thoracic plus lumbar measurements for spinal mobility assessment?
No full textAdvanced technologies for measuring human mobility have recently emerged, such as motion capture systems, inertial measurement units (IMUs), and wearable devices. Some of these are used to assess mobility in patients with rheumatic diseases. Certain devices focus solely on assessing lumbar mobility. However, Axial Spondyloarthritis (axSpA) reduces spinal mobility across all spinal segments, not just the lumbar region. The objective of this study was to analyze the contribution of the thoracic spine to overall spinal mobility and determine whether this contribution should be considered in the metrological assessment of patients with axSpA. A total of 20 patients with axSpA and 20 age-, BMI-, and sex-matched healthy controls were recruited. Spinal mobility was measured using an IMU-based system (ViMove©), which employs two IMU sensors and calculates the angle between them in real time. Two tests were performed: one using the standard anatomical positions (pelvis and L1) and another combining lumbar and thoracic movement (pelvis and T3). Conventional metrology, radiographic structural damage in axSpA patients, and patient-reported outcomes (PROs) were also collected. The results table displays the mobility measurements for lumbar only and lumbar + thoracic movement in both groups. The thoracic spine’s contribution is expressed as a percentage of total movement. Pearson correlation coefficients (for axSpA patients only) with conventional metrology (BASMI), PROs (BASDAI, BASFI, and ASQoL), and structural damage (mSASSS) are also presented.S
Vol. 30, nº 08. La utilidad clínica y organizativa de las teleconsultas.
No full textEnfermedades de Declaración Obligatoria por provincias. Semana 07/2025 y acumulado desde la semana 01/2025. Datos provisionales. Incluye además el artículo titulado “La utilidad clínica y organizativa de las teleconsultas”, de “Paola Tatiana García Giraldo,, Soledad Benot López”.Ye
Vol. 30, nº 35. Gripe aviar: situación actual en Andalucía.
No full textEnfermedades de Declaración Obligatoria por provincias. Semana 22/2025 y acumulado desde la semana 01/2025. Datos provisionales. Incluye además el artículo titulado “Gripe aviar: situación actual en Andalucía”, del “Servicio de Vigilancia y Salud Laboral”.Ye
Vol. 30, nº 34. La población ante las adicciones: 2024.
No full textEnfermedades de Declaración Obligatoria por provincias. Semana 36/2025 y acumulado desde la semana 01/2025. Datos provisionales. Incluye además el artículo titulado “La población ante las adicciones: 2024”, de “Izaskun Bilbao Acedo”.N
Monitoring of the oncological process for lung cancer in Spain: an expert consensus report.
No full textIntroduction: Continuous monitoring of the oncological process is essential for identifying inefficiencies and areas of improvement, enabling better resource allocation in the care of lung cancer patients.
Objective: The objective is to define key indicators and identify critical variables for monitoring lung cancer care, aiming to improve early detection, reduce delays in diagnosis and treatment, and enhance biomarker research, ensuring timely and effective treatments for all patients.
Methods: A multidisciplinary expert group conducted a consensus process based on a review of national guidelines and initiatives related to lung cancer care. The experts defined relevant indicators and identified variables for monitoring overall care, addressing delays, and improving biomarker research. The feasibility of incorporating these indicators into existing information systems was also assessed.
Results: The proposed indicators provide a structured approach for assessing lung cancer care and outcomes. Their inclusion in healthcare information systems would improve the monitoring and evaluation of care quality and patient outcomes. Additionally, these indicators would also promote interoperability and continuous patient care across different centers and regions, allowing informed decision-making in the improvement of healthcare processes by those responsible for healthcare management.
Conclusions: The adoption of standardized indicators for lung cancer care monitoring can drive continuous improvement in healthcare processes. Implementing these indicators in information systems will enable better resource allocation, timely and effective treatment, and enhanced coordination among healthcare providers, ultimately improving patient outcomes.Ye
Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement
No full textHeart failure (HF) secondary to tachycardia-induced cardiomyopathy (TIC) is often underdiagnosed due to inconsistent definitions and perceived reversibility. The treatment focuses on early arrhythmia control, but the impact of guideline-directed medical therapy (GDMT) on left ventricular ejection fraction (LVEF) improvement has not been fully explored. This multicentric prospective registry study included patients with newly onset HF and reduced ejection fraction (HFrEF). Data were collected on clinical characteristics, echocardiographic and laboratory parameters, pharmacological treatment, and follow-up events. The statistical analyses focused on TIC patients, analyzing the event rates and the influence of GDMT on LVEF improvement according to sinus rhythm (SR) restoration. Among 808 patients, 174 (21.5%) were diagnosed with TIC, with an age of 67.2 (SD: 9.4) years. After a median follow-up of 3.5 months [IQR: 2.6-4.3], SR was restored in 56.8% of patients, and LVEF improved from 29.6 to 49%. The increase was more pronounced in patients who restored SR compared to those remaining in atrial fibrillation (AF) (22.4% vs. 15.1%; p < 0.05). The natriuretic peptides significantly decreased in the SR group (- 1883.7 pg/mL) but did not in the AF group. The overall readmission rate was 25.1% and the overall mortality rate was 3.6%, with no significant differences between patients who achieved SR and those with persistent AF at the end of up-titration. HF readmission was infrequent (4%) despite AF persistence. Early GDMT was initiated in TIC patients, regardless of SR recovery and significantly improved LVEF, especially in AF patients [RR = 4.24 (95% CI: 1.44-12.45)] compared to SR patients [(RR = 1.41 95% CI: 1.02-1.92)]. TIC represents a significant proportion of HFrEF patients, with early restoration of SR leading to greater LVEF improvement. Despite AF persistence, HF readmissions were rare, highlighting the efficacy of early quadruple therapy. Enhanced adherence to GDMT should be prioritized, particularly in patients with persistent AF.Ye
Vol. 30, nº 09-10. Informe sobre adicciones comportamentales y otros trastornos adictivos en España: 2024
No full textEnfermedades de Declaración Obligatoria por provincias. Semana 09/2025 y acumulado desde la semana 01/2025. Datos provisionales. Incluye además el artículo titulado “Informe sobre adicciones comportamentales y otros trastornos adictivos en España: 2024”, de “Carla Torralba Suárez”.Ye